TrialCancer chemotherapy and pharmacology2019

A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer.

Yasuhiro Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.